Indianapolis, INDIANA1 Active Studies

Substance Use Disorder Clinical Trials in Indianapolis, INDIANA

Find 1 actively recruiting substance use disorder clinical trials in Indianapolis, INDIANA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
200
Enrolling

Recruiting Substance Use Disorder Studies in Indianapolis

About Substance Use Disorder Clinical Trials in Indianapolis

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 200 participants. Research is being sponsored by Indiana University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Indianapolis — FAQ

Are there substance use disorder clinical trials in Indianapolis?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov